Investigation of Structure-Activity Relationships for Benzoyl and Cinnamoyl Piperazine/Piperidine Amides as Tyrosinase Inhibitors

被引:3
|
作者
Varela, Marina T. [1 ]
Levatti, Erica V. de Castro [2 ]
Tempone, Andre G. [2 ]
Fernandes, Joao Paulo S. [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Pharmaceut Sci, BR-09913030 Diadema, SP, Brazil
[2] Butantan Inst, Lab Pathophysiol, BR-05503900 Sao Paulo, SP, Brazil
来源
ACS OMEGA | 2023年 / 8卷 / 46期
基金
巴西圣保罗研究基金会;
关键词
MUSHROOM TYROSINASE; ACID; MECHANISM; SITE;
D O I
10.1021/acsomega.3c06977
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Melanin is a substance that plays important roles in several organisms. Its function as an antioxidant and metal-complexing agent makes tyrosinase, the key enzyme that controls melanogenesis, an interesting target for designing inhibitors. In this article, we report a set of piperazine/piperidine amides of benzoic and cinnamic acid derivatives as tyrosinase inhibitors with improved potency and drug-likeness. The most potent compound 5b showed a pIC(50) of 4.99 in the monophenolase assay, and only compound 3a showed reasonable potency in the diphenolase assay (pIC(50), 4.18). These activities are not correlated to antiradical activity, suggesting that the activity is dependent on competition with the substrates. Molecular docking studies indicated that the benzyl substituent of 5b and other analogues perform important interactions in the enzyme that may explain the higher potency of these compounds. Moreover, the compounds present adequate lipophilicity and skin permeability and no relevant cytotoxicity (CC50 > 200 mu M) to mammalian cells.
引用
收藏
页码:44265 / 44275
页数:11
相关论文
共 50 条
  • [41] Inhibitors of vitamin D hydroxylases: Structure-activity relationships
    Schuster, I
    Egger, H
    Nussbaumer, P
    Kroemer, RT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) : 372 - 380
  • [42] Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors
    Williams, MA
    Lew, W
    Mendel, DB
    Tai, CY
    Escarpe, PA
    Laver, WG
    Stevens, RC
    Kim, CU
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) : 1837 - 1842
  • [43] Structure-activity relationships of novel potent MurF inhibitors
    Gu, YG
    Florjancic, AS
    Clark, RF
    Zhang, TY
    Cooper, CS
    Anderson, DD
    Lerner, CG
    McCall, JO
    Cai, YN
    Black-Schaefer, CL
    Stamper, GF
    Hajduk, PJ
    Beutel, BA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 267 - 270
  • [44] The development of novel telomerase inhibitors: Structure-activity relationships
    Cheng, MK
    Modi, C
    Grindon, CR
    Stevens, MFG
    Laughton, CA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S40 - S40
  • [45] Structure-activity relationships of PDE5 inhibitors
    Eros, D.
    Szantai-Kis, Cs.
    Kiss, R.
    Keri, Gy.
    Hegymegi-Barakonyi, B.
    Koevesdi, I.
    Orfi, L.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (16) : 1570 - 1585
  • [46] Structure-activity relationships of some complex I inhibitors
    Miyoshi, H
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02): : 236 - 244
  • [47] STRUCTURE-ACTIVITY RELATIONSHIPS OF MONOAMINE-OXIDASE INHIBITORS
    FUJITA, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (08) : 923 - 930
  • [48] Electronic-topological study of the structure-activity relationships in a series of piperidine morphinomimetics
    Sim, E
    Dimoglo, A
    Shvets, N
    Ahsen, V
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (16) : 1537 - 1545
  • [49] Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure-Activity Relationships
    Kumar, Ravi Ranjan
    Sahu, Bhaskar
    Pathania, Shelly
    Singh, Pankaj Kumar
    Akhtar, M. Jawaid
    Kumar, Bhupinder
    CHEMMEDCHEM, 2021, 16 (12) : 1878 - 1901
  • [50] Characterization of tyrosinase inhibitors in the twigs of Cudrania tricuspidata and their structure-activity relationship study
    Zheng, Zong-Ping
    Tan, Hui-Yuan
    Chen, Jie
    Wang, Mingfu
    FITOTERAPIA, 2013, 84 : 242 - 247